Mirum Pharmaceuticals, Inc.MIRMNASDAQ
LOADING
|||
EBITDA Over Time
Trending higher, above historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-48.97M
↑ 37% above average
Average (6y)
$-77.94M
Historical baseline
Range
High:$-17.33M
Low:$-136.49M
CAGR
+18.9%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-48.97M | +64.1% |
| 2023 | $-136.49M | -11.1% |
| 2022 | $-122.85M | -87.9% |
| 2021 | $-65.39M | +36.1% |
| 2020 | $-102.31M | -96.0% |
| 2019 | $-52.21M | -201.2% |
| 2018 | $-17.33M | - |